Tahuanty Pena - Academia.edu (original) (raw)

Related Authors

Leslie Tutty

Francis Dupuis-Déri

Joan Meier

Yasser El-Wazir

Janus Ong‡

University Of The Philippines College Of Medicine

Kate Rittenhouse-Olson

P. Piyachaturawat

Patricia C Prodigalidad

Uploads

Papers by Tahuanty Pena

Research paper thumbnail of eComment. Lung size mismatch and graft dysfunction immediately after reperfusion

Interactive cardiovascular and thoracic surgery, 2016

Research paper thumbnail of Pulmonary Mass in an Immunocompromised Patient: Think Outside the Box

Respiratory Care, Jul 1, 2009

Research paper thumbnail of How to minimise ventilator-induced lung injury in transplanted lungs: The role of protective ventilation and other strategies

European journal of anaesthesiology, Jan 2, 2015

Lung transplantation is the treatment of choice for end-stage pulmonary diseases. In order to avo... more Lung transplantation is the treatment of choice for end-stage pulmonary diseases. In order to avoid or reduce pulmonary and systemic complications, mechanical ventilator settings have an important role in each stage of lung transplantation. In this respect, the use of mechanical ventilation with a tidal volume of 6 to 8 ml kg predicted body weight, positive end-expiratory pressure of 6 to 8 cmH2O and a plateau pressure lower than 30 cmH2O has been suggested for the donor during surgery, and for the recipient both during and after surgery. For the present review, we systematically searched the PubMed database for articles published from 2000 to 2014 using the following keywords:lung transplantation, protective mechanical ventilation, lung donor, extracorporeal membrane oxygenation, recruitment manoeuvres, extracorporeal CO2 removal and noninvasive ventilation.

Research paper thumbnail of Mechanical ventilation for the lung transplant recipient

Current Pulmonology Reports, 2015

Mechanical ventilation (MV) is an important aspect in the intraoperative and early postoperative ... more Mechanical ventilation (MV) is an important aspect in the intraoperative and early postoperative management of lung transplant (LTx)-recipients. There are no randomized-controlled trials of LTx-recipient MV strategies; however there are LTx center experiences and international survey studies reported. The main early complication of LTx is primary graft dysfunction (PGD), which is similar to the adult respiratory distress syndrome (ARDS). We aim to summarize information pertinent to LTx-MV, as well as PGD, ARDS, and intraoperative MV and to synthesize these available data into recommendations. Based on the available evidence, we recommend lung-protective MV with low-tidal-volumes (≤6 mL/kg predicted body weight [PBW]) and positive end-expiratory pressure for the LTx-recipient. In our opinion, the MV strategy should be based on donor characteristics (donor PBW as a parameter of actual allograft size), rather than based on recipient characteristics; however this donor-characteristics-based protective MV is based on indirect evidence and requires validation in prospective clinical studies.

Research paper thumbnail of Effect Of Azithromycin On The Course Of FEV1 In Bronchiolitis Obliterans Syndrome After Stem Cell Transplantation?

C47. MANAGEMENT AND OUTCOMES AFTER LUNG TRANSPLANT, 2011

Research paper thumbnail of Outcomes Of Cardiopulmonary Resuscitation In Cancer Patients Admitted To The Medical Intensive Care Unit

D103. END OF LIFE CARE, 2011

Research paper thumbnail of Pulmonary Mass in an Immunocompromised Patient: Think Outside the Box

Research paper thumbnail of A rare cause of syncope and pulmonary opacities

Research paper thumbnail of Pulmonary Metastasis of Basal Cell Carcinoma

Journal of Thoracic Oncology, 2009

Research paper thumbnail of Aspergillus Lung Disease in Patients with Sarcoidosis: A Case Series and Review of the Literature

Lung, 2011

Chronic cavitary pulmonary aspergillosis (CCPA) has been associated with advanced lung diseases. ... more Chronic cavitary pulmonary aspergillosis (CCPA) has been associated with advanced lung diseases. Pulmonary sarcoidosis, a granulomatous inflammatory disorder, is associated with CCPA. We identified CCPA in 2% of cases in a large cohort of sarcoidosis patients. We found a lack of response to medical treatment and poor outcome in this subgroup.

Research paper thumbnail of eComment. Lung size mismatch and graft dysfunction immediately after reperfusion

Interactive cardiovascular and thoracic surgery, 2016

Research paper thumbnail of Pulmonary Mass in an Immunocompromised Patient: Think Outside the Box

Respiratory Care, Jul 1, 2009

Research paper thumbnail of How to minimise ventilator-induced lung injury in transplanted lungs: The role of protective ventilation and other strategies

European journal of anaesthesiology, Jan 2, 2015

Lung transplantation is the treatment of choice for end-stage pulmonary diseases. In order to avo... more Lung transplantation is the treatment of choice for end-stage pulmonary diseases. In order to avoid or reduce pulmonary and systemic complications, mechanical ventilator settings have an important role in each stage of lung transplantation. In this respect, the use of mechanical ventilation with a tidal volume of 6 to 8 ml kg predicted body weight, positive end-expiratory pressure of 6 to 8 cmH2O and a plateau pressure lower than 30 cmH2O has been suggested for the donor during surgery, and for the recipient both during and after surgery. For the present review, we systematically searched the PubMed database for articles published from 2000 to 2014 using the following keywords:lung transplantation, protective mechanical ventilation, lung donor, extracorporeal membrane oxygenation, recruitment manoeuvres, extracorporeal CO2 removal and noninvasive ventilation.

Research paper thumbnail of Mechanical ventilation for the lung transplant recipient

Current Pulmonology Reports, 2015

Mechanical ventilation (MV) is an important aspect in the intraoperative and early postoperative ... more Mechanical ventilation (MV) is an important aspect in the intraoperative and early postoperative management of lung transplant (LTx)-recipients. There are no randomized-controlled trials of LTx-recipient MV strategies; however there are LTx center experiences and international survey studies reported. The main early complication of LTx is primary graft dysfunction (PGD), which is similar to the adult respiratory distress syndrome (ARDS). We aim to summarize information pertinent to LTx-MV, as well as PGD, ARDS, and intraoperative MV and to synthesize these available data into recommendations. Based on the available evidence, we recommend lung-protective MV with low-tidal-volumes (≤6 mL/kg predicted body weight [PBW]) and positive end-expiratory pressure for the LTx-recipient. In our opinion, the MV strategy should be based on donor characteristics (donor PBW as a parameter of actual allograft size), rather than based on recipient characteristics; however this donor-characteristics-based protective MV is based on indirect evidence and requires validation in prospective clinical studies.

Research paper thumbnail of Effect Of Azithromycin On The Course Of FEV1 In Bronchiolitis Obliterans Syndrome After Stem Cell Transplantation?

C47. MANAGEMENT AND OUTCOMES AFTER LUNG TRANSPLANT, 2011

Research paper thumbnail of Outcomes Of Cardiopulmonary Resuscitation In Cancer Patients Admitted To The Medical Intensive Care Unit

D103. END OF LIFE CARE, 2011

Research paper thumbnail of Pulmonary Mass in an Immunocompromised Patient: Think Outside the Box

Research paper thumbnail of A rare cause of syncope and pulmonary opacities

Research paper thumbnail of Pulmonary Metastasis of Basal Cell Carcinoma

Journal of Thoracic Oncology, 2009

Research paper thumbnail of Aspergillus Lung Disease in Patients with Sarcoidosis: A Case Series and Review of the Literature

Lung, 2011

Chronic cavitary pulmonary aspergillosis (CCPA) has been associated with advanced lung diseases. ... more Chronic cavitary pulmonary aspergillosis (CCPA) has been associated with advanced lung diseases. Pulmonary sarcoidosis, a granulomatous inflammatory disorder, is associated with CCPA. We identified CCPA in 2% of cases in a large cohort of sarcoidosis patients. We found a lack of response to medical treatment and poor outcome in this subgroup.

Log In